Jeffrey Schneider, MD | Authors

Articles

The Benefits of myPlan to Help Identify High-Risk Patients With NSCLC

November 24, 2016

Jeffrey Schneider, MD, chief of hematology and medical oncology, Winthrop University Hospital, discusses the benefits of Myriad's myPlan in determining high-risk patients with non-small cell lung cancer (NSCLC).